Director, Global HEOR
Cornerstone Search Group
Boston, MA · Posted October 10, 2026
More in Massachusetts job market · Pharmaceuticals & Biotech
About the job
Director, Global HEOR Location Hybrid, Greater Boston Area, United States of America Job Type Full-time Description Director, Global HEOR | Top Boston Commercial-Stage Pharma – focus on high-profile, clinical-stage, rare disease biologic | RETAINED SEARCH Director, Global HEOR [ RETAINED SEARCH ] Top Boston Commercial-Stage Pharma Focus on high-profile, clinical-stage, rare disease biologic with multiple indications Cornerstone Search Group’s HEOR/Market Access Practice is pleased to be retained once again by a leading Boston-area pharmaceutical company renowned for operating at the forefront of scientific innovation, successfully launching multiple breakthrough medicines, and having top-notch talent. They are seeking a technically strong HEOR professional with very good communication skills for a newly created and critical Global HEOR position that will focus on a high-profile, first-in-class potential, clinical-stage biologic asset projected to be a multi-blockbuster with multiple and diverse immunology-related rare disease indications. Location LOCATION: Boston Metro Area – 3 days per week on-site is required RELOCATION: Full relocation assistance is available. Features 5 HIGHLY ATTRACTIVE FEATURES: High-Profile Impact: This newly created, highly visible role focuses on a clinical-stage biologic that is potentially first-in-class, has multiple and diverse rare disease indication approval potential, and is anticipated to be a multi-blockbuster. Stable and Growing Company: In an era of instability and staff cutbacks by companies of all sizes, our client’s scientific and strategic acumen has led to continued growth, providing organizational stability and demonstrated career progression for multiple HEOR professionals. Strong HEOR Leadership: Our client’s HEOR department has steady, proven, high-EQ leadership whom we know quite well. Attractive to Directors : Our client offers highly competitive compensation, LTI, relocation, and sign-on bonus programs along with a highly regarded department leader and a demonstrated history of internal career growth. This position can thus be very attractive to experienced HEOR Directors. Opportunity to Gain Global Experience : Our client is willing to consider a high-potential individual who does not yet have strong global experience as the hiring manager has such experience and is a willing mentor. COMPENSATION: Highly competitive base and bonus along with aggressive LTI program, generous PTO, and excellent benefits. Responsibilities KEY ACCOUNTABILITIES: Develop HEOR strategy for multiple immunology / auto-immune indications ranging from early development through product lifecycle. Work with cross-functional and cross-regional teams to align strategic plans. Gather and synthesize insights from Payers and KOLs. Plan, design, and execute HEOR evidence generation including observational studies (prospective and retroactive), CEA and BIM, ITCs, meta-analyses and systematic reviews, and COA/PRO. Supports the integration of HEOR evidence in HTA submissions. Collaborates cross-functionally on publication strategy and HEOR evidence dissemination. Partner closely with your global pricing and global market access colleagues to support production of global value dossier. Qualifications / Requirements DESIRED SKILLS/ QUALIFICATIONS / EXPERIENCES / BEHAVIORS: MA/MS, MPH, PharmD, PhD, or MD 5+ years of relevant experience Strategic and analytical thinker who can connect clinical-stage evidence generation activities to business and clinical priorities. A hands-on project leader with strong execution skills and attention to detail. A track record of formulating and leading creative and scientifically rigorous research projects. Technical strengths in data analytics, database research, RWE, and outcomes research. Experience preparing publications and presenting scientific findings. Our client does not require therapeutic areas of experience. High EQ (emotional intelligence) coupled with persuasive communication, presentation, and influencing skills across internal and external stakeholders. Contact Corey S. Ackerman, JD Email: cackerman@cornerstonesg.com Phone: 973-656-0220x716 LinkedIn: http://www.linkedin.com/in/coreyackerman Cornerstone Search Group, LLC 1200 Morris Turnpike | Short Hills, New Jersey 07078, USA www.cornerstonesg.com Recently Completed Retained Searches by Cornerstone REPRESENTATIVE RETAINED SEARCH ASSIGNMENTS: CEO | specialty pharma start-up CEO | regenerative medicine start-up US CEO | established European small pharma President/US Commercial Head | Generics Pharma CMO | late-stage public biotech CMO | mid-size pharma CSO | mid-size global biotech SVP, Head of Global Medical Affairs | mid-size oncology company SVP, Head of Global Clinical Development | multi-TA mid-size pharma SVP, Head of Global Regulatory Affairs | late-stage Israeli biotech Global Head, Oncology R&D | mid-size European pharma Group VP, Global Commercial Head | API Business Unit | Indian pharma VP, Data Science RWE | Top 5 Pharma VP, Head of Regulatory Affairs | Boston Biotech VP, US Head of Regulatory Affairs | Top 20 Pharma VP, Head of R&D Operations | Boston biotech VP, Head of HEOR (Health Economics & Outcomes Research | Top CNS specialty pharma VP, Head of US HEOR & RWE | Top 5 Pharma VP, Head of Real-World Evidence | Top 5 pharma VP, Head of US HEOR | Top Oncology Pharma ED, Head of HEOR | Top West Coast Pharma VP, Head of Global Market Access | Top Oncology Specialty Pharma VP, Head of US Market Access | High-profile late-stage biotech VP, Head of US Market Access | West Coast Late-Stage Public Biotech VP, Head of Heme/Onc Clinical Research | Public oncology biotech VP, Head of Clinical Development | late-stage anti-infectives UK pharma VP, Head of Global Drug Safety & PV | Chinese oncology biotech ED, Head of Clinical Operations | British VC-backed biotech ED, Global Commercial Strategy Franchise Head | Top rare disease Boston pharma ED, Head of Global Clinical Pharmacol